Heidelberg Pharma Ag operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Heidelberg Pharma Ag with three other
companies in this sector in GERMANY :
MediGene AG
(2019
sales of 10.63 million Euro [US$12.90 million]
of which 92%
was Immunotherapies),
Northern Data AG
(10.16 million Euro [US$12.33 million]
), and
4Sc AG
(2.20 million Euro [US$2.67 million]
).
Sales Analysis.
Heidelberg Pharma Ag reported sales of 7.31 million Euro (US$8.87 million)
for the
fiscal
year ending
November of 2019.
This
represents
an
increase of 99.3%
versus 2018, when the company's sales were 3.67 million Euro.
This was the third consecutive year of growth at Heidelberg Pharma Ag.